The 32 most recent market catalysts affecting $ISRG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 9, 2026
Corporate Catalyst
Bearish
Impact 75
Intuitive Surgical Executive Says The Company's U.S. Business, Accounting For ~60% Of Its Operations, Is Decelerating; Company's Growth Drivers Expected To Remain Broadly Consistent In 2026 YoY
Intuitive Surgical's executive commentary on a conference call revealed a deceleration in its U.S. business, which is a significant concern given it accounts for 60% of the company…
Sep 8, 2026
Corporate Catalyst
Neutral
Impact 55
Intuitive Surgical Published Systematic Review And Meta-Analysis In Peer-Reviewed Annals Of Surgery Open.
This headline indicates a positive corporate catalyst for Intuitive Surgical (ISRG). The publication of a systematic review and meta-analysis in a peer-reviewed journal like Annals…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 75
Oppenheimer Upgrades Intuitive Surgical to Outperform, Announces $500 Price Target
Oppenheimer analyst Suraj Kalia upgraded Intuitive Surgical (ISRG) from a 'Perform' rating to an 'Outperform' rating, simultaneously establishing a $500 price target. This upgrade …
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 65
HSBC Downgrades Intuitive Surgical to Hold, Announces $931 Price Target
HSBC analyst Helen Fang downgraded Intuitive Surgical (ISRG) from a 'Buy' to a 'Hold' rating, simultaneously announcing a $931 price target. This action signals a more tempered out…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 55
Raymond James Maintains Outperform on Intuitive Surgical, Lowers Price Target to $483
Raymond James analyst Jayson Bedford maintained an 'Outperform' rating on Intuitive Surgical (ISRG) but significantly lowered the price target from $577 to $483. This action signal…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 95
Intuitive Surgical Stock Sinks to 52-Week Low - Here's Why
Intuitive Surgical (ISRG) experienced a sharp decline in its stock price due to several converging headwinds. The company reported a moderation in U.S. procedure growth, particular…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 65
Piper Sandler Reiterates Overweight on Intuitive Surgical, Lowers Price Target to $470
Piper Sandler's decision to lower Intuitive Surgical's price target by $110, from $580 to $470, despite maintaining an 'Overweight' rating, indicates a recalibration of valuation e…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 75
Shares of medical device companies are trading lower amid sympathy with Intuitive Surgical after the company reported Q2 financial results and noted that the China market remains a challenge. Also, multiple analysts lowered their respective price targets on ISRG.
This headline indicates a significant negative catalyst for the medical device sector. Intuitive Surgical's poor Q2 performance, particularly the challenges in the crucial China ma…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 65
JP Morgan Maintains Overweight on Intuitive Surgical, Lowers Price Target to $450
JP Morgan's analyst Robbie Marcus maintained an 'Overweight' rating on Intuitive Surgical, suggesting a continued positive long-term outlook for the company. However, the substanti…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 60
Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $400
Mizuho analyst Anthony Petrone maintained a 'Neutral' rating on Intuitive Surgical (ISRG) but notably lowered the price target from $500 to $400. This action signals a more cautiou…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 65
Wells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $487
Wells Fargo analyst Larry Biegelsen maintained an 'Overweight' rating on Intuitive Surgical (ISRG), indicating a continued positive long-term outlook for the company. However, the …
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 55
Stifel Maintains Buy on Intuitive Surgical, Lowers Price Target to $550
Stifel's decision to maintain a 'Buy' rating while simultaneously lowering the price target for Intuitive Surgical (ISRG) from $670 to $550 signals a nuanced shift in analyst senti…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 92
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
The filing indicates a significant negative sentiment in the pre-market, primarily due to disappointing corporate results and outlooks. Intuitive Surgical, despite beating analyst …
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 55
Bernstein Maintains Outperform on Intuitive Surgical, Lowers Price Target to $685
Bernstein analyst Lee Hambright maintained an 'Outperform' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's long-term prospects. However, the pr…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 65
Leerink Partners Maintains Outperform on Intuitive Surgical, Lowers Price Target to $454
Leerink Partners, through analyst Mike Kratky, maintained an 'Outperform' rating on Intuitive Surgical (ISRG), indicating a continued belief in the company's long-term prospects. H…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 75
Intuitive Surgical shares are trading lower after the company reported Q2 financial results and during a conference call, an executive said that the China environment remains a challenge. BTIG and Baird lowered their respective price targets on the stock.
The headline highlights a direct corporate catalyst: Intuitive Surgical's Q2 earnings report and subsequent executive commentary. The negative sentiment stems from the 'China envir…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 85
These Analysts Slash Their Forecasts On Intuitive Surgical Following Q2 Earnings
Intuitive Surgical (ISRG) announced Q2 earnings and revenue that surpassed analyst consensus estimates. However, the stock experienced an 11.1% drop in pre-market trading, suggesti…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 55
Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $500
Baird analyst David Rescott maintained an 'Outperform' rating on Intuitive Surgical (ISRG) but lowered the price target from $525 to $500. This action signals a slight reduction in…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 55
BTIG Maintains Buy on Intuitive Surgical, Lowers Price Target to $469
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's long-term prospects. However, the price target w…
Jul 16, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Thursday's After-Market Session
This filing highlights after-market trading activity for a selection of healthcare stocks, indicating volatility outside of regular trading hours. The movements are largely company…
Jul 16, 2026
Corporate Catalyst
Bearish
Impact 65
Intuitive Surgical Exec Says China Environment Remains Challenging; Continues To See Increased Domestic Robotic Competition And Policy-Driven Pricing Pressure
During a conference call, an Intuitive Surgical executive highlighted persistent difficulties in the Chinese market, specifically citing heightened domestic competition in robotic …
Jul 16, 2026
Corporate Catalyst
Bearish
Impact 90
Intuitive Surgical Stock Falls Despite Q2 Earnings Beat
Intuitive Surgical (ISRG) announced impressive Q2 2026 results, surpassing analyst expectations for both EPS and revenue, driven by robust growth in da Vinci and Ion procedures and…
Jul 16, 2026
Corporate Catalyst
Bearish
Impact 85
Intuitive Surgical shares are trading lower. The company reported Q2 financial results.
The headline indicates a direct corporate catalyst: Intuitive Surgical's Q2 earnings. The immediate negative share price reaction suggests the results likely missed analyst estimat…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 92
Intuitive Surgical Q2 Adj. EPS $2.80 Beats $2.50 Estimate, Sales $2.892B Beat $2.820B Estimate
Intuitive Surgical (ISRG) announced Q2 adjusted EPS of $2.80, surpassing the $2.50 consensus estimate by 12%, and sales of $2.892 billion, beating the $2.820 billion estimate by 2.…
Jul 16, 2026
Corporate Catalyst
Bearish
Impact 55
Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $510
Truist Securities analyst Richard Newitter lowered the price target for Intuitive Surgical (ISRG) from $580 to $510, while maintaining a 'Buy' rating. This action suggests that whi…
Jul 15, 2026
Corporate Catalyst
Bearish
Impact 55
Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $500
Mizuho analyst Anthony Petrone has adjusted Intuitive Surgical's (ISRG) price target downwards from $525 to $500, while keeping a 'Neutral' rating. This action signals a slightly r…
Jul 14, 2026
Corporate Catalyst
Bearish
Impact 75
Intuitive Surgical Stock Hits 52-Week Lows: What's Going On?
Intuitive Surgical (ISRG) shares have plummeted to a 52-week low, primarily driven by a broader medical device sector downturn following HCA Healthcare's warning about declining su…
Jul 13, 2026
Corporate Catalyst
Bearish
Impact 65
TD Cowen Maintains Buy on Intuitive Surgical, Lowers Price Target to $520
TD Cowen analyst Mathew Blackman has adjusted their price target for Intuitive Surgical (ISRG) from $585 to $520, although they continue to recommend a 'Buy' rating. This action in…
Jul 13, 2026
Corporate Catalyst
Bearish
Impact 55
RBC Capital Maintains Outperform on Intuitive Surgical, Lowers Price Target to $600
RBC Capital analyst Shagun Singh maintained an 'Outperform' rating on Intuitive Surgical (ISRG), signaling continued confidence in the company's fundamentals and long-term growth p…
Jul 13, 2026
Corporate Catalyst
Neutral
Impact 65
Intuitive Surgical Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
The filing is an earnings preview for Intuitive Surgical (ISRG) ahead of its Q2 report on July 16. Analysts are projecting higher earnings per share and revenue compared to the yea…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.